Business Practice

Business & Regulation Business Practice

Trump Targets Pharma

01/19/2017 | James Strachan

“We’re going to start bidding,” says Trump. Are we about to see changes to Medicare?

Manufacture Business Practice

Failure to Engage

01/19/2017 | Stephanie Vine

Could public health suffer if the pharma industry doesn’t learn to win back trust?

Discovery & Development Business Practice

In Conversation with Franco Negron of Patheon at CPhI Worldwide 2016

01/04/2017

The Medicine Maker's Charlotte Barker speaks with Franco Negron from Patheon

Discovery & Development Business Practice

In Conversation with Andreas Gryczke of BASF at CPhI Worldwide 2016

01/04/2017

The Medicine Maker's Charlotte Barker speaks with Andreas Gryczke from BASF

Discovery & Development Business Practice

In Conversation with Matthias Bucerius of Merck KGaA at CPhI Worldwide 2016

01/04/2017

The Medicine Maker's Charlotte Barker speaks with Dr Matthias Bucerius from Merck KGaA

Discovery & Development Business Practice

In Conversation with Bernhard Paul of Johnson Matthey at CPhI Worldwide 2016

01/04/2017

The Medicine Maker's Charlotte Barker speaks with Bernhard Paul from Johnson Matthey

Discovery & Development Business Practice

In Conversation with Gary Lord of Dow Corning Healthcare at CPhI Worldwide 2016

01/04/2017

The Medicine Maker's Charlotte Barker speaks with Gary Lord from Dow Corning Healthcare

Discovery & Development Business Practice

In Conversation with Simon Edwards of Cambrex at CPhI Worldwide 2016

01/04/2017

The Medicine Maker's Charlotte Barker speaks with Simon Edwards from Cambrex

Discovery & Development Business Practice

In Conversation with Dr Jean Luc Herbeaux of Evonik at CPhI Worldwide 2016

01/04/2017

The Medicine Maker's Charlotte Barker speaks with Dr Jean Luc Herbeaux from Evonik

Manufacture Business Practice

Direct visualization, sizing and concentration measurements of drug delivery nanoparticles

12/22/2016

In this application note, we discuss how Nanoparticle Tracking Analysis (NTA) is used to measure the size and concentration of nanoparticles used for drug delivery, such as liposomes, in order to determine efficacy and rate of uptake, degradation and clearance from the body.

...
56
57
58
59
60
...

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine